Similarly, in laryngeal cancer cells TU212 and TU686, stable transfectants with high CTSL expression exhibited an increase in IL6‐JAK‐STAT3 pathway activity, while low expression stable transfectants showed a decrease (Figure 5G–J). Here, IL6 is linked to laryngeal carcinoma.